25.07.2013 Views

Udredning og behandling af demens - Sundhedsstyrelsen

Udredning og behandling af demens - Sundhedsstyrelsen

Udredning og behandling af demens - Sundhedsstyrelsen

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

233. Caro J, Salas M, Ward A, Getsios D, Migliaccio-Walle K, Garfield F. Assessing<br />

the health and economic impact of galantamine treatment in patients with alzheimer’s<br />

disease in the health care systems of different countries. Drugs Aging. 2004;21:677.<br />

234. Jones RW, McCrone P, Guilhaume C. Cost effectiveness of memantine in alzheimer’s<br />

disease: An analysis based on a probabilistic markov model from a UK perspective.<br />

Drugs Aging. 2004;21:607.<br />

235. Weycker D, et al. Cost-effectiveness of memantine in moderate-to-severe alzheimer’s<br />

disease patients receiving donepezil. Curr Med Res Opin. 2007;23:1187.<br />

236. Kirby J, et al. A systematic review of the clinical and cost-effectiveness of memantine<br />

in patients with moderately severe to severe alzheimer’s disease. Drugs Aging.<br />

2006;23:227.<br />

237. Birks J, Harvey RJ. Donepezil for dementia due to alzheimer’s disease. Cochrane<br />

Database Syst Rev. 2006(CD001190).<br />

238. Green C, Picot J, Loveman E, Takeda A, Kirby J, Clegg A. Modelling the cost<br />

effectiveness of cholinesterase inhibitors in the management of mild to moderately<br />

severe alzheimer’s disease. Pharmacoeconomics. 2005;23:1271.<br />

239. Getsios D, Migliaccio-Walle K, Caro JJ. NICE cost-effectiveness appraisal of cholinesterase<br />

inhibitors: Was the right question posed? were the best tools used?<br />

Pharmacoeconomics. 2007;25(12):997-1006.<br />

240. Kronborg Andersen C, Lauridsen J, Andersen K, Kragh-Sorensen P. Cost of<br />

dementia: Impact of disease pr<strong>og</strong>ression estimated in longitudinal data. Scand J Public<br />

Health. 2003;31:119.<br />

241. Sørensen J, Gudex CM, Kronborg Andersen C. Demenssygdommes fremtidige<br />

økonomiske belastning <strong>af</strong> social- <strong>og</strong> sundhedsvæsenet. Ugeskr Læger. 2006;168:3432.<br />

242. Lægemiddelstatistikregistret [homepage on the Internet]. [cited 25.02.08].<br />

Available from: http://www.medstat.dk/.<br />

243. Covinsky KE, Newcomer R, Fox P, Wood J, Sands L, Dane K, et al. Patient and<br />

caregiver characteristics associated with depression in caregivers of patients with<br />

dementia. J Gen Intern Med. 2003 Dec;18(12):1006-14.<br />

244. Fyns Amt. Forstærket indsats for udredning <strong>af</strong> <strong>demens</strong> i fyns amt – en medicinsk<br />

teknol<strong>og</strong>ivurdering. . 2001.<br />

245. Lov Om Ændring Af Lægeloven, lov nr. 351 <strong>af</strong> 14/5, 1992).<br />

246. Lov Om Patienters Retsstilling, LOV nr. 482 <strong>af</strong> 01/07, 1998).<br />

247. Sundhedsloven, LBK nr. 95, Kapitel 5, § 15 (07-02-2008).<br />

154 <strong>Udredning</strong> <strong>og</strong> <strong>behandling</strong> <strong>af</strong> <strong>demens</strong> – en medicinsk teknol<strong>og</strong>ivurdering

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!